Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pactiv Evergreen
(NASDAQ:PTVE)
Intraday
$14.52
0.38
[2.69%]
After-Hours
$14.52
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$14.52
0.38
[2.69%]
At close: Apr 19
$14.52
0
[0.00%]
After Hours: 4:17PM EDT
Get Report
Watch
Q1 2024 Earnings in 13 days from now on Thu May 2nd, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Pactiv Evergreen Stock (NASDAQ:PTVE)
Pactiv Evergreen Stock (NASDAQ: PTVE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
Where Pactiv Evergreen Stands With Analysts
Benzinga Insights
-
Apr 4, 2024, 3:01PM
Citigroup Maintains Buy on Pactiv Evergreen, Raises Price Target to $17
Benzinga Newsdesk
-
Apr 4, 2024, 12:11PM
Monday, March 04, 2024
Expert Outlook: Pactiv Evergreen Through The Eyes Of 9 Analysts
Benzinga Insights
-
Mar 4, 2024, 2:00PM
RBC Capital Reiterates Outperform on Pactiv Evergreen, Maintains $18 Price Target
Benzinga Newsdesk
-
Mar 4, 2024, 11:26AM
These Analysts Revise Their Forecasts On Pactiv Evergreen After Q4 Results
Avi Kapoor
-
Mar 4, 2024, 8:19AM
Citigroup Maintains Buy on Pactiv Evergreen, Lowers Price Target to $15
Benzinga Newsdesk
-
Mar 4, 2024, 8:12AM
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Mar 4, 2024, 7:56AM
Goldman Sachs Maintains Neutral on Pactiv Evergreen, Raises Price Target to $14
Benzinga Newsdesk
-
Mar 4, 2024, 7:32AM
Baird Maintains Neutral on Pactiv Evergreen, Raises Price Target to $15
Benzinga Newsdesk
-
Mar 4, 2024, 7:03AM
Friday, March 01, 2024
Pactiv Evergreen shares are trading lower after the company reported mixed Q4 financial results.
Benzinga Newsdesk
-
Mar 1, 2024, 12:36PM
Thursday, February 29, 2024
Pactiv Evergreen Sees FY24 Adj. EBITDA $850M-$870M
Benzinga Newsdesk
-
Feb 29, 2024, 4:48PM
Pactiv Evergreen Sees Q1 2024 Adj. EBITDA $160M-$170M
Benzinga Newsdesk
-
Feb 29, 2024, 4:48PM
Pactiv Evergreen: Q4 Earnings Insights
Benzinga Insights
-
Feb 29, 2024, 4:25PM
Pactiv Evergreen Q4 2023 Adj EPS $0.330 Beats $0.210 Estimate, Sales $1.274B Miss $1.319B Estimate
Benzinga Newsdesk
-
Feb 29, 2024, 4:21PM
Earnings Scheduled For February 29, 2024
Benzinga Insights
-
Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Earnings Preview For Pactiv Evergreen
Benzinga Insights
-
Feb 28, 2024, 2:00PM
Cramer Says This AI Stock Is Just An Nvidia Play, Prefers This Stock Over Anheuser-Busch
Avi Kapoor
-
Feb 28, 2024, 8:57AM
Tuesday, February 13, 2024
5 Analysts Have This To Say About Pactiv Evergreen
Benzinga Insights
-
Feb 13, 2024, 12:00PM
Friday, January 19, 2024
Jefferies Initiates Coverage On Pactiv Evergreen with Buy Rating, Announces Price Target of $18
Benzinga Newsdesk
-
Jan 19, 2024, 6:16AM
Tuesday, January 16, 2024
Pactiv Evergreen Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
-
Jan 16, 2024, 12:01PM
UBS Initiates Coverage On Pactiv Evergreen with Buy Rating, Announces Price Target of $19
Benzinga Newsdesk
-
Jan 16, 2024, 11:29AM
Thursday, January 11, 2024
Top 5 Materials Stocks That Are Ticking Portfolio Bombs
Avi Kapoor
-
Jan 11, 2024, 7:55AM
Wednesday, January 03, 2024
Citigroup Upgrades Pactiv Evergreen to Buy, Raises Price Target to $16
Benzinga Newsdesk
-
Jan 3, 2024, 8:07AM
Tuesday, January 02, 2024
B of A Securities Upgrades Pactiv Evergreen to Buy, Raises Price Target to $16
Benzinga Newsdesk
-
Jan 2, 2024, 7:23AM
Thursday, November 09, 2023
Top 2 Materials Stocks You May Want To Dump This Quarter
Lisa Levin
-
Nov 9, 2023, 8:29AM
Friday, November 03, 2023
RBC Capital Maintains Outperform on Pactiv Evergreen, Raises Price Target to $13
Benzinga Newsdesk
-
Nov 3, 2023, 3:16PM
Thursday, November 02, 2023
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 2, 2023, 2:26PM
Pactiv Evergreen shares are trading higher after the company reported mixed Q3 financial results.
Benzinga Newsdesk
-
Nov 2, 2023, 1:39PM
Starbucks, Teleflex, Roku, Shopify And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Nov 2, 2023, 11:01AM
Wednesday, November 01, 2023
Pactiv Evergreen Q3 2023 Adj EPS $0.32 Beats $0.20 Estimate, Sales $1.38B Miss $1.39B Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 4:29PM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
Wednesday, September 27, 2023
Pactiv Evergreen And ExxonMobil Collaborate To Leverage Advanced Recycling For Foodservice Industry Packaging
Benzinga Newsdesk
-
Sep 27, 2023, 4:13PM
Thursday, August 10, 2023
Citigroup Maintains Neutral Rating for Pactiv Evergreen: Here's What You Need To Know
Benzinga Insights
-
Aug 10, 2023, 1:00PM
Citigroup Maintains Neutral on Pactiv Evergreen, Raises Price Target to $9
Benzinga Newsdesk
-
Aug 10, 2023, 11:50AM
Friday, August 04, 2023
RBC Capital Maintains Outperform on Pactiv Evergreen, Raises Price Target to $11
Benzinga Newsdesk
-
Aug 4, 2023, 11:49AM
Wednesday, August 02, 2023
Pactiv Evergreen Q2 Adj $0.20 Misses $0.21 Estimate, Sales $1.43B Miss $1.53B Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 4:51PM
Pactiv Sees FY23 Adj. EBITDA $775M-$800M
Benzinga Newsdesk
-
Aug 2, 2023, 4:25PM
Pactiv Evergreen Q2 Sales $1.43B Miss $1.53B Estimate
Benzinga Newsdesk
-
Aug 2, 2023, 4:24PM
Earnings Scheduled For August 2, 2023
Benzinga Insights
-
Aug 2, 2023, 8:45AM
Tuesday, August 01, 2023
Earnings Outlook For Pactiv Evergreen
Benzinga Insights
-
Aug 1, 2023, 2:01PM
Tuesday, July 11, 2023
Citigroup Reiterates Neutral on Pactiv Evergreen, Maintains $8 Price Target
Benzinga Newsdesk
-
Jul 11, 2023, 10:43AM
Tuesday, May 30, 2023
Gaotu Techedu, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
Lisa Levin
-
May 30, 2023, 6:13AM
Tuesday, May 23, 2023
Pactiv Evergreen's Return On Capital Employed Overview
Benzinga Insights
-
May 23, 2023, 10:47AM
Wednesday, May 10, 2023
Mizuho Maintains Buy on Pactiv Evergreen, Lowers Price Target to $11
Benzinga Newsdesk
-
May 10, 2023, 7:09AM
Monday, May 08, 2023
Pactiv Evergreen Q1 EPS $(0.76) Misses $0.07 Estimate, Sales $1.43B Miss $1.44B Estimate
Benzinga Newsdesk
-
May 8, 2023, 4:34PM
Earnings Scheduled For May 8, 2023
Benzinga Insights
-
May 8, 2023, 9:03AM
Thursday, May 04, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
May 4, 2023, 12:29PM
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Apr 26, 2023, 2:37PM
Friday, March 24, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
-
Mar 24, 2023, 12:05PM
Wednesday, March 15, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Mar 15, 2023, 1:25PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch